Bayer-Stock
Bayer Stock

Investor Information

Performance of Bayer Stock over the Past Twelve Months
The price of Bayer stock was relatively stable from early January to mid-February 2009 within a narrow range from €41.60 to €44.29. From mid-February onward, however, Bayer shares mirrored the general market decline, closing at €36.00 on March 31, 2009, down 13.4% from the closing price on December 31, 2008.
The DAX lost 15.1% in the same period, closing the quarter at 4,085 points. The European reference index EURO STOXX 50 also fell by 15.1% from the beginning of the year, closing at 3,174 points on March 31, 2009.
Bayer Stock Key Data 1st
Quarter
2008
1st
Quarter
2009
Full Year 2008
High for the period65.6844.2965.68 
Low for the period45.9032.6936.83 
Average daily share turnover on
German stock exchanges

million

7.4

5.1

6.0

      
  

March 31, 2008


March 31, 2009


Dec. 31,
2008

Change
March 31, 2009/
Dec. 31, 2008

%

Share price50.7636.0041.55-13.4
Market capitalization€ million38,79827,51631,758-13.4
Equity as per statements of financial position€ million17,60517,09416,340+4.6
Number of shares entitled to the dividendmillion764.34764.34764.340.0
      
DAX 6,5354,0854,810-15.1

XETRA closing prices (source: Bloomberg)

Calculation of core earnings per share

Earnings per share according to IFRS are affected by the purchase price allocation for acquisitions and other special factors. To enhance comparability, we also determine core net income from continuing operations after elimination of the amortization of intangible assets, asset write-downs (including any impairment losses), special items in EBITDA including the related tax effects, and one-time tax income or expense.
The calculation of earnings per share in accordance with IFRS is explained in the Notes to the Condensed Consolidated Interim Financial Statements. Adjusted core net income, core earnings per share and core EBIT are not defined in the IFRS. Therefore they should be regarded as supplementary information rather than stand-alone indicators.

Calculation of core EBIT and core earnings per share
1st Quarter
2008
1st Quarter
2009
 € million€ million
EBIT as per income statements1,343 973
Amortization and write-downs of intangible assets407 378
Write-downs of property, plant and equipment31 13
Special items (other than write-downs)130 34
Core EBIT1,911 1,398
Non-operating result (as per income statements)(275)(334)
Income taxes (as per income statements)(306)(215)
Tax adjustment(173)(127)
Income after taxes attributable to non-controlling interest
(as per income statements)

0

1
Core net income from continuing operations1,157 723
Financing expenses for the mandatory convertible bond, net of tax effects28 28
Adjusted core net income1,185 751


Shares

Shares
Weighted average number of issued ordinary shares764,341,920 764,343,660
Potential shares to be issued upon conversion
of the mandatory convertible bond

59,582,699

60,039,083
Adjusted weighted average total number of issued
and potential ordinary shares

823,924,619

824,382,743
Core earnings per share from continuing operations (€)1.44 0.91
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
top
Print page
Search
Search
Advanced Search
Download Center
 
Links
Annual Report 2008
 
Financial Reports
 
Comparison
Services
Order print version
 
Event Reminder
 
Press Newsletter
 
Would you like to be kept informed about new financial reports from Bayer?
 
SMS Service
Calendar
Investor Conference Call
 
Annual Stockholders' Meeting 2009
Info
Notes on our information package and all services